You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

CLINICAL TRIALS PROFILE FOR RYBREVANT


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for RYBREVANT

Trial ID Title Status Sponsor Phase Start Date Summary
NCT05379595 ↗ A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer Not yet recruiting Janssen Research & Development, LLC Phase 1/Phase 2 2022-09-19 The purpose of this study is to assess the anti-tumor activity of amivantamab as a monotherapy (Cohorts A, B, and C), to characterize the safety of amivantamab when added to standard-of care (SoC) chemotherapy in participants with metastatic colorectal cancer (mCRC) (Ph2 cohorts), and to assess the recommended phase 2 combination dose (RP2CD) of amivantamab when added to SoC chemotherapy (Ph1b cohorts).
NCT05395052 ↗ FT536 Monotherapy and in Combination With Monoclonal Antibodies in Advanced Solid Tumors Recruiting Fate Therapeutics Phase 1 2022-05-01 This is a Phase 1 dose-finding study of FT536 monotherapy and in combination with monoclonal antibodies.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for RYBREVANT

Condition Name

Condition Name for RYBREVANT
Intervention Trials
Advanced or Metastatic Colorectal Cancer 1
Breast Cancer 1
Colorectal Cancer 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for RYBREVANT
Intervention Trials
Colorectal Neoplasms 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for RYBREVANT

Trials by Country

Trials by Country for RYBREVANT
Location Trials
United States 8
Germany 1
Spain 1
France 1
Malaysia 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for RYBREVANT
Location Trials
North Carolina 1
Washington 1
Texas 1
Tennessee 1
New York 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for RYBREVANT

Clinical Trial Phase

Clinical Trial Phase for RYBREVANT
Clinical Trial Phase Trials
Phase 1/Phase 2 1
Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for RYBREVANT
Clinical Trial Phase Trials
Not yet recruiting 1
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for RYBREVANT

Sponsor Name

Sponsor Name for RYBREVANT
Sponsor Trials
Janssen Research & Development, LLC 1
Fate Therapeutics 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for RYBREVANT
Sponsor Trials
Industry 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.